1-115286557-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002506.3(NGF):​c.239G>A​(p.Arg80Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,614,182 control chromosomes in the GnomAD database, including 224 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R80W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.011 ( 18 hom., cov: 32)
Exomes 𝑓: 0.015 ( 206 hom. )

Consequence

NGF
NM_002506.3 missense

Scores

2
10
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 3.04

Publications

27 publications found
Variant links:
Genes affected
NGF (HGNC:7808): (nerve growth factor) This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene's expression is associated with allergic rhinitis. [provided by RefSeq, Jul 2008]
NGF-AS1 (HGNC:53922): (NGF antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009551585).
BP6
Variant 1-115286557-C-T is Benign according to our data. Variant chr1-115286557-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 291991.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0115 (1751/152300) while in subpopulation NFE AF = 0.0179 (1221/68034). AF 95% confidence interval is 0.0171. There are 18 homozygotes in GnomAd4. There are 815 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NGFNM_002506.3 linkc.239G>A p.Arg80Gln missense_variant Exon 3 of 3 ENST00000369512.3 NP_002497.2
NGFNM_001437545.1 linkc.239G>A p.Arg80Gln missense_variant Exon 2 of 2 NP_001424474.1
NGFXM_011541518.3 linkc.404G>A p.Arg135Gln missense_variant Exon 3 of 3 XP_011539820.1
NGF-AS1NR_157569.1 linkn.207+3317C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NGFENST00000369512.3 linkc.239G>A p.Arg80Gln missense_variant Exon 3 of 3 1 NM_002506.3 ENSP00000358525.2

Frequencies

GnomAD3 genomes
AF:
0.0115
AC:
1750
AN:
152182
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0105
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.00213
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.0113
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0179
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.0104
AC:
2609
AN:
251144
AF XY:
0.0108
show subpopulations
Gnomad AFR exome
AF:
0.00303
Gnomad AMR exome
AF:
0.00422
Gnomad ASJ exome
AF:
0.00903
Gnomad EAS exome
AF:
0.00152
Gnomad FIN exome
AF:
0.0103
Gnomad NFE exome
AF:
0.0168
Gnomad OTH exome
AF:
0.00995
GnomAD4 exome
AF:
0.0147
AC:
21482
AN:
1461882
Hom.:
206
Cov.:
30
AF XY:
0.0144
AC XY:
10442
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00257
AC:
86
AN:
33480
American (AMR)
AF:
0.00467
AC:
209
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00926
AC:
242
AN:
26136
East Asian (EAS)
AF:
0.000957
AC:
38
AN:
39700
South Asian (SAS)
AF:
0.00323
AC:
279
AN:
86258
European-Finnish (FIN)
AF:
0.0112
AC:
600
AN:
53412
Middle Eastern (MID)
AF:
0.0127
AC:
73
AN:
5768
European-Non Finnish (NFE)
AF:
0.0172
AC:
19174
AN:
1112010
Other (OTH)
AF:
0.0129
AC:
781
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
1486
2971
4457
5942
7428
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0115
AC:
1751
AN:
152300
Hom.:
18
Cov.:
32
AF XY:
0.0109
AC XY:
815
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.00361
AC:
150
AN:
41566
American (AMR)
AF:
0.0105
AC:
160
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3470
East Asian (EAS)
AF:
0.00213
AC:
11
AN:
5160
South Asian (SAS)
AF:
0.00560
AC:
27
AN:
4822
European-Finnish (FIN)
AF:
0.0113
AC:
120
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0179
AC:
1221
AN:
68034
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
95
190
286
381
476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0146
Hom.:
53
Bravo
AF:
0.0106
TwinsUK
AF:
0.0173
AC:
64
ALSPAC
AF:
0.0197
AC:
76
ESP6500AA
AF:
0.00613
AC:
27
ESP6500EA
AF:
0.0147
AC:
126
ExAC
AF:
0.0108
AC:
1308
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0175
EpiControl
AF:
0.0152

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital sensory neuropathy with selective loss of small myelinated fibers Benign:5
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 26, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 28, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

NGF-related disorder Benign:1
Mar 18, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.50
D
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.97
D
MetaRNN
Benign
0.0096
T
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Pathogenic
3.3
M
PhyloP100
3.0
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-2.7
D
REVEL
Benign
0.22
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.057
T
Polyphen
1.0
D
Vest4
0.19
MPC
1.2
ClinPred
0.050
T
GERP RS
5.1
Varity_R
0.55
gMVP
0.64
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11466111; hg19: chr1-115829178; COSMIC: COSV65687443; API